Chapter 2 - Neoplasms (C00-D49)»Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)»Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission (C92.20)

C92.20

Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission

Related indications (MeSH) (2)

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative134 drugs (105 approved, 29 experimental)

A myelodysplastic/myeloproliferative disorder characterized by myelodysplasia associated with bone marrow and peripheral blood patterns similar to CHRONIC MYELOID LEUKEMIA, but cytogenetically lacking a PHILADELPHIA CHROMOSOME or bcr/abl fusion gene (GENES, ABL).

Myelodysplastic Syndromes750 drugs (272 approved, 478 experimental)

Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.